Matrix metalloprotease-7 is associated with post-COVID-19 persistent lung abnormalities

被引：0
作者：
Buendia-Roldan, Ivette
Chavez-Galan, Leslie
Aguilar-Duran, Hiram [1 ]
Ruiz, Andy [1 ]
Falfan-Valencia, Ramces
Perez-Rubio, Gloria [1 ]
Pardo, Annie [2 ]
Selman, Moises [1 ]
机构：
[1] Inst Nacl Enfermedades Resp Ismael Cosio, Mexico City, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, Mexico
来源：
ERJ OPEN RESEARCH | 2024年 / 10卷 / 06期
关键词：
PULMONARY-FIBROSIS; OSTEOPONTIN;
D O I：
10.1183/23120541.00266-2024
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study
    Mehrdad Nabahati
    Soheil Ebrahimpour
    Reza Khaleghnejad Tabari
    Rahele Mehraeen
    Egyptian Journal of Radiology and Nuclear Medicine, 52
  • [32] Challenges in the Management of Post-COVID-19 Pulmonary Fibrosis for the Latin American Population
    Cherrez-Ojeda, Ivan
    Cortes-Telles, Arturo
    Gochicoa-Rangel, Laura
    Camacho-Leon, Genesis
    Mautong, Hans
    Robles-Velasco, Karla
    Faytong-Haro, Marco
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (09):
  • [33] Tackling pulmonary fibrosis risks in post-COVID-19: cutting-edge treatments
    Duong-Quy, Sy
    Hai, Cong Nguyen
    Huynh-Anh, Tuan
    Nguyen-Nhu, Vinh
    EXPERT OPINION ON PHARMACOTHERAPY, 2025, 26 (01) : 75 - 84
  • [34] Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
    Cirjaliu, Roxana-Elena
    Deacu, Mariana
    Gherghisan, Ioana
    Marghescu, Angela Stefania
    Enciu, Manuela
    Baltatescu, Gabriela Izabela
    Nicolau, Antonela Anca
    Tofolean, Doina-Ecaterina
    Arghir, Oana Cristina
    Fildan, Ariadna-Petronela
    BIOMEDICINES, 2023, 11 (06)
  • [35] Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?
    Bari, Elia
    Ferrarotti, Ilaria
    Saracino, Laura
    Perteghella, Sara
    Torre, Maria Luisa
    Richeldi, Luca
    Corsico, Angelo Guido
    CELLS, 2021, 10 (05)
  • [36] Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group
    Salvi, Sundeep Santosh
    Ghorpade, Deesha
    Dhoori, Sahajal
    Dhar, Raja
    Dumra, Harjit
    Chhajed, Prashant N.
    Bhattacharya, Parathasarathi
    Rajan, Sujeet
    Talwar, Deepak
    Christopher, Devasahayam J.
    Mohan, Murali
    Udwadia, Zarir
    LUNG INDIA, 2022, 39 (02) : 177 - 186
  • [37] Prospects for the Use of Marine Sulfated Fucose-Rich Polysaccharides in Treatment and Prevention of COVID-19 and Post-COVID-19 Syndrome
    Kiselevskiy, M., V
    Anisimova, N. Yu
    Bilan, M., I
    Usov, A., I
    Ustyuzhanina, N. E.
    Petkevich, A. A.
    Shubina, I. Zh
    Morozevich, G. E.
    Nifantiev, N. E.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2022, 48 (06) : 1109 - 1122
  • [38] Post COVID-19 Chronic Parenchymal Lung Changes
    Touman, Abdelfattah
    Kahyat, Mohammed
    Bulkhi, Adeeb
    Khairo, Mutaz
    Alyamani, Wael
    Aldobyany, Ahmad M.
    Ghaleb, Nabil
    Ashi, Hadeel
    Alsobaie, Mohammed
    Alqurashi, Eid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [39] Clinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis A case-control study
    Farghaly, Shereen
    Badedi, Mohammed
    Ibrahim, Rehab
    Sadhan, Murad H.
    Alamoudi, Aymn
    Alnami, Awaji
    Muhajir, Abdulrahman
    MEDICINE, 2022, 101 (03) : E28639
  • [40] New grading system for post-COVID-19 pulmonary fibrosis based on computed tomography findings
    Demircioglu, Ozlem
    Kocakaya, Derya
    Cimsit, Canan
    Cimsit, Nuri Cagatay
    MEDICINE, 2022, 101 (35) : E30146
12345